EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 23 / No 2 (Février 2007) Med Sci (Paris), 23 2 (2007) 198-204 References
Free Access
Issue
Med Sci (Paris)
Volume 23, Number 2, Février 2007
Page(s) 198 - 204
Section M/S revues
DOI https://doi.org/10.1051/medsci/2007232198
Published online 15 February 2007
  1. Kavlock RJ, Daston GP, DeRosa C, et al. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect 1996; 104 (suppl 4) : 715–40. [Google Scholar]
  2. Toppari J, Larsen JC, Christiansen P, et al. Male reproductive health and environmental xenœstrogens. Environ Health Perspect 1996; 104 (suppl 4) : 741–803. [Google Scholar]
  3. Jégou B, Auger J, Multigner L, et al. The saga of the sperm count decrease in humans and wild and farm animals. In : Gagnon C, ed. The male gamete : from basic sciences to clinical applications. Vienna, IL, USA : Cache River Press 1999 : 445–54. [Google Scholar]
  4. Eustache F, Auger J, Cabrol D, Jouannet P. Are volunteers delivering semen samples in fertility studies a biased population ? Hum Reprod 2004; 19 : 2831–7. [Google Scholar]
  5. Auger J, Kunstmann JM, Czyclik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 1995; 332 : 281–5. [Google Scholar]
  6. Swan SH, Main KM, Liu F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005; 113 : 1056–61. [Google Scholar]
  7. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001; 16 : 972–8. [Google Scholar]
  8. Slama R, Bouyer J, Remontet L, Spira A. Epidemiology of male reproductive function: a field searching for tools. Rev Epidemiol Sante Publ 2004; 52 : 221–42. [Google Scholar]
  9. Jensen TK, Joffe M, Scheike T, et al. Time trends in waiting time to pregnancy among Danish twins. Hum Reprod 2005; 20 : 955–64. [Google Scholar]
  10. Boisen K, Chellakooty M, Schmidt I, et al. Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at 3 months of age. J Clin Endocrinol Metab 2005; 90 : 4041–6. [Google Scholar]
  11. Cheek OA, Kow K, Chen J, McLachlan JA. Potential mechanisms of thyroid disruption in humans : interaction of organochlorine compounds with thyroid receptor, transthyretin and thyroid-binding globulin. Environ. Health Perspect 1999; 107 : 273–8. [Google Scholar]
  12. Arcaro KF, Yi L, Seegal RF, et al. 2,2’, 6, 6’-tetrachlorobiphenyl is œstrogenic in vitro and in vivo. J Cell Biochem 1999; 72 : 94–102. [Google Scholar]
  13. Kester MHA, Bulduk S, Tibboel D, et al. Potent inhibition of œstrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the œstrogenic activity of PCBs. Endocrinology 2000; 141 : 1897–1900. [Google Scholar]
  14. Mocarelli P, Gerthoux PM, Ferrari E, et al. Paternal concentrations of dioxin and sex ratio of offspring. Lancet 2000; 355 : 1858–63. [Google Scholar]
  15. Meerts IA, Letcher RJ, Hoving S, et al. In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds. Environ Health Perspect 2001; 109 : 399–407. [Google Scholar]
  16. Acevedo R, Parnell PG, Villanueva H, et al. The contribution of hepatic steroid metabolism to serum estradiol concentrations in nonylphenol treated MMTVneu mice and its potential effects on breast cancer incidence and latency. J Appl Toxicol 2005; 25 : 339–53. [Google Scholar]
  17. Calafat AM, Kuklenyik Z, Reidy JA, et al. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113 : 391–5. [Google Scholar]
  18. Markey CM, Luque EH, Munoz de Toro MM, et al. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 2001; 65 : 1215–23. [Google Scholar]
  19. Timms BG, Howdeshell KL, Barton L, et al. Œstrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 2005; 102 : 7014–9. [Google Scholar]
  20. Zalko D, Soto AM, Dolo L, et al. Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ Health Perspect 2003; 111 : 309–19. [Google Scholar]
  21. Saillenfait AM, Laudet-Lesbert A. Phtalates. EMC-Toxicologie-Pathologie, Elsevier Paris, France 2005; 2 : 1–13. [Google Scholar]
  22. Foster PM. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl 2006; 29 : 140–7. [Google Scholar]
  23. Mahood IK, McKinnell C, Walker M, et al. Cellular origins of testicular dysgenesis in rats exposed in utero to di(n-butyl) phthalate. Int J Androl 2006; 29 : 148–54. [Google Scholar]
  24. Zacharewski TR, Meek MD, Clemons JH, et al. Examination of the in vitro and in œstrogenic activities of eight commercial phthalate esters. Toxicol Sci 1998; 46 : 282–93. [Google Scholar]
  25. Colon I, Caro D, Bourdony CJ, Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect 2000; 108 : 895–900. [Google Scholar]
  26. Taylor JR, Selhorst JB, Houff SA, Martinez AJ. Chlordecone in toxication in man. I. Clinical observations. Neurology 1978; 28 : 626–30. [Google Scholar]
  27. Shelby MD, Newbold RR, Tully DB, et al. Assessing environmental chemicals for œstrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect 1996; 104 : 1296–300. [Google Scholar]
  28. Monosson E, Kelce WR, Lambright C, et al. Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male. Toxicol Ind Health 1999; 65–79. [Google Scholar]
  29. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308 : 1466–9. [Google Scholar]
  30. Barnes S. Evolution of the health benefits of soy isoflavones. Proc Soc Exp Biol Med 1998; 217 : 386–92. [Google Scholar]
  31. Bennetau-Pelissero C, Latonnelle K, Séqueira A, Lamothe V. Phytœstrogens, endocrine disrupters from food. Analusis 2000; 28 : 763–75. [Google Scholar]
  32. Murphy PA, Song T, Buseman G, et al. Isoflavones in retail and institutional soy foods. J Agric Food Chem 1999; 47 : 2697–704. [Google Scholar]
  33. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Isoflavone content of infant formulas and the metabolic fate of these phytœstrogens in early life. Am J Clin Nutr 1998; 68 (suppl) : S1453–61. [Google Scholar]
  34. Hilakivi-Clarke L, Cho E, Onojafe I, et al. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumoregenesis in female rat offspring. Oncol Rep 1999; 6 : 1089–95. [Google Scholar]
  35. Newbold RR, Padilla Banks E, Bullock B, Jefferson WN. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 2001; 61 : 4325–8. [Google Scholar]
  36. Drash AL, Kramer MS, Swanson J, Udall JN. Infant breeding practices and their possible relationship to the etiology of diabetes mellitus. Pediatrics 1994; 94 : 752–4. [Google Scholar]
  37. North K, Golding J. A maternal vegetarian diet in pregnancy is associated with hypospadias. Br J Urol Int 2000; 85 : 107–13. [Google Scholar]
  38. Europa-environment. How the European commission uses the precautionary principle to tackle endocrine disrupters. Bruxelles : UE, 2005. http://europa.eu.int/comm/environment/endocrine/. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.